Data / Drug companies / Methylprednisolone acetate
Methylprednisolone acetate: 10 companies and 36 products in the FDA NDC directory
Methylprednisolone acetate is listed in the FDA National Drug Code Directory by 10 companies, with 36 products in commercial distribution. 22 of the products (61.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, suspension, and the newest product started marketing on November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 10
- Products
- 36
- Generic (ANDA) products
- 22 (61.1%)
- Application numbers
- 7
- Routes
- Intralesional, Intramuscular, Soft tissue, Intra-articular, Intrasynovial
- Brand names
- Depo-Medrol, Depo-Medrol, Medroloan II Suik, Medroloan Suik
- openFDA record search
- api.fda.gov
Companies that list methylprednisolone acetate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 6 | injection, suspension | New drug applications (NDA) | May 20, 2019 |
| Pharmacia & Upjohn Company LLC | 6 | injection, suspension | New drug applications (NDA) | May 28, 1959 |
| Amneal Pharmaceuticals LLC | 5 | injection, suspension | Generic drugs (ANDA) | November 10, 2023 |
| Gland Pharma Limited | 5 | injection, suspension | Generic drugs (ANDA) | November 2, 2026 |
| Asclemed USA, Inc. | 3 | injection, suspension | Other unapproved drugs | June 29, 2016 |
| Sportpharm LLC | 3 | injection, suspension | Generic drugs (ANDA) | November 15, 2021 |
| Amneal Pharmaceuticals NY LLC | 2 | injection, suspension | Generic drugs (ANDA) | April 10, 2022 |
| Caplin Steriles Limited | 2 | injection, suspension | Generic drugs (ANDA) | February 6, 2026 |
| Eugia US LLC | 2 | injection, suspension | Generic drugs (ANDA) | April 13, 2023 |
| Sagent Pharmaceuticals | 2 | injection, suspension | Generic drugs (ANDA) | November 15, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, suspension | 36 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 61.1% |
| New drug applications (NDA) | 12 | 33.3% |
| Other unapproved drugs | 2 | 5.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| Corticosteroid | 36 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.